Clinical trials: Palmar Hyperhidrosis
Hyperhidrosis, Palmar Hyperhidrosis
Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis
This is a multicenter, randomized, double-blind, placebo-controlled, parallel group comparison study of AT-5214 in subjects with moderate to severe primary palmar hyperhidrosis (sweaty palms).
- Trial name
- NCT04263623
- Testing
- Dexmecamylamine HCl
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- Atacama Therapeutics
Hyperhidrosis, Children, Adolescents
Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18
In this study, the investigators aim to present fifteen years' experience of thoracoscopic sympathetic chain interruption for primary palmar hyperhidrosis in children and adolescents; evaluation of 3 different techniques…
- Conditions
- Hyperhidrosis, Children, Adolescents, Thoracoscopic Sympathetic Chain Interruption, Sympathetic Disorder
- Trial name
- MISforPPH (NCT06113978)
- Testing
- Thoracoscopic sympathectomy, Thoracoscopic sympathotomy, Thoracoscopic sympathetic chain clipping
- Where
- Egypt
- Volunteers
- 420 people
- Sponsor
- dr. Muhammad Abdelhafez Mahmoud, MD
Excessive Sweating of the Hands
Phenol With Fluoroscopy Guided Radiofrequency Ablation of T2-T3in Palmar Hyperhidrosis.
Primary hyperhidrosis is a disorder characterized by excessive and chronic sweating in the absence of a sweating trigger. The disorder can be severe and interfere with normal daily activities of the patients.
- Trial name
- NCT03506828
- Testing
- Surgical sympathectomy, Radiofrequency ablation with phenol injection
- Where
- Egypt
- Volunteers
- 82 people
- Sponsor
- Mansoura University
Hyperhidrosis, Hyperhidrosis Palmaris et Plantaris
Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis
This study will evaluate the use of hydrogel electrode pads (rather than tap water baths) to deliver iontophoresis treatment using a traditional iontophoresis device.
- Trial name
- NCT02854540
- Testing
- Hydrogel electrode-based iontophoresis
- Where
- 2 sites in United States
- Volunteers
- 13 people
- Sponsor
- Stanford University
Palmar Hyperhidrosis
Fluorescent Thoracoscopy Used in Surgery for Palmar Hyperhidrosis
T3/T4 endoscopic thoracic sympathicotomy is a widely accepted and effective treatment for primary palmar hyperhidrosis. However, sympathetic ganglions are invisible with traditional thoracoscopy and until now, the location of…
- Trial name
- NCT03840655
- Testing
- Near-Infrared Imaging Thoracoscopy
- Where
- China
- Volunteers
- 89 people
- Sponsor
- Peking University People's Hospital
Hyperhidrosis Due to Autonomic Dysregulation (Disorder)
Extended Versus Limited Thoracoscopic Sympathectomy: Its Impact on Palmar and Plantar Hyperhidrosis
Conclusions: In the context of palmar and plantar hyperhidrosis, extended thoracoscopic sympathectomy seemed to be preferred over limited thoracoscopic sympathectomy due to better overall outcomes and minimal time for hospital…
- Trial name
- NCT06219655
- Testing
- thoracoscopic sympathectomy
- Where
- Egypt
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Mansoura University
Compensatory Hyperhidrosis, Recurrence
T3 Versus T4 Sympathicotomy for Treatment of Primary Palmar Hyperhidrosis
T3 versus T4 as a primary treatment for palmer hyperhydrosis and effect on postoperative compensatory hyperhydrosis
- Trial name
- NCT01295853
- Testing
- t3 sympathicotomy, t4 symapthicotomy
- Where
- Egypt
- Volunteers
- 136 people
- Sponsor
- Mansoura University
Palmar Hyperhidrosis
A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
The objective of this study is to assess the efficacy and safety of glycopyrronium cloth, 2.4% when used to treat palmar hyperhidrosis.
- Trial name
- NCT03880266
- Testing
- Glycopyrronium cloth, 2.4%, Vehicle
- Where
- 7 sites in United States
- Volunteers
- 72 people
- Sponsor
- Journey Medical Corporation
Hyperhidrosis
The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis
Hyperhidrosis or sweating of palms results from the overactivity of sweat glands and leads to psychosocial impairment with reduction in quality of life in those that are affected.
- Trial name
- NCT03203174
- Testing
- Microneedle, Botulinum Toxin Type A, Saline
- Where
- United States
- Volunteers
- 13 people, healthy volunteers welcome
- Sponsor
- University of California, Davis
Hyperhidrosis, Quality of Life
Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4.
Compare the results obtained with video-assisted sympathectomy performed in two distinct levels ganglionic (third versus fourth thoracic ganglion) for the treatment of palmar hyperhidrosis, through a blind randomized clinical…
- Trial name
- NCT01140659
- Testing
- Video-assisted sympathectomy
- Where
- Brazil
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Sao Paulo
Palmar Hyperhidrosis
Unilateral Sequential Sympathectomy for Palmar Hyperhidrosis
Comparison between unilateral sequential and bilateral simultaneous endoscopic thoracic sympathectomy for palmar hyperhidrosis on patients outcomes notably compensatory hyperhidrosis.
- Trial name
- ETS (NCT02321332)
- Testing
- bilateral simultaneous endoscopic thoracic symapthectomy, unilateral sequential endoscopic thoracic symapthectomy.
- Volunteers
- 400 people
- Sponsor
- Tmaer Youssef Mohamed
Primary Focal Hyperhidrosis of the Hands
BTX-A Treatment for Palmar Hyperhidrosis
Primary focal hyperhidrosis (excessive sweating) is a debilitating condition affecting approximately 3% of the population in the United States.
- Trial name
- NCT01262339
- Testing
- BTX-A
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- University of Wisconsin, Madison
Hyperhidrosis
Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis
Hyperhidrosis is defined as excessive sweating and affects about 2.8 % of the population. It has been shown to have a deleterious effect on the quality of life measured using the Dermatology Life Quality Index (DLQI) which is one…
- Trial name
- NCT01930604
- Testing
- Botox (onabotulinumtoxinA), NeuroBloc/Myobloc (rimabotulinumtoxinB)
- Where
- Sweden
- Volunteers
- 588 people
- Sponsor
- Carl Swartling
Palmar Hyperhidrosis, Hyperhidrosis
An Open Label Study for Palmar Hyperhydrosis
The purpose of this open-label study is to evaluate the efficacy and safety of different methods of application of glycopyrronium cloth, 2.4% in patients with palmar hyperhidrosis
- Conditions
- Palmar Hyperhidrosis, Hyperhidrosis, Sweat Gland Diseases, Skin Diseases
- Trial name
- NCT04906655
- Testing
- Glycopyrronium 2.4 % Medicated Cloth
- Where
- United States
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Pariser, Robert J., M.D.